Steve Gorlin - 09 Nov 2023 Form 4 Insider Report for BIOVIE INC. (BIVI)

Reporting relationship: Director
Issuer ticker: BIVI
Reported as of: 09 Nov 2023
Net transaction value: -$127,899
SEC form: 4
Accepted by SEC: 06 Dec 2023, 16:16:27 UTC
Prior SEC filing: 07 Sep 2023
Source filing: View source filing
Reporting owner signature: /S/ STEVE GORLIN

Key filing fact

Steve Gorlin filed Form 4 for BIOVIE INC. (BIVI) on 06 Dec 2023.

Key facts

This page summarizes Steve Gorlin's Form 4 filing for BIOVIE INC. (BIVI).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 06 Dec 2023, 16:16.

Change

Previous filing in this sequence was filed on 07 Sep 2023.
Current net transaction value: -$127,899.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIVI transaction

Common Stock

Award

Transaction value: $0
Shares: +46,358
Change %: +61%
Price: $0.000000
Shares after: 122,038
Date: 09 Nov 2023
Ownership: Direct
Footnotes: F1

BIVI transaction

Common Stock

Sale

Transaction value: $127,899
Shares: -75,680
Change %: -62%
Price: $1.69
Shares after: 46,358
Date: 01 Dec 2023
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting.